blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1302205

EP1302205 - Controlled release formulations of macrolide citrate salts [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.02.2006
Database last updated on 24.04.2024
Most recent event   Tooltip11.01.2008Lapse of the patent in a contracting state
New state(s): SE		published on 13.02.2008  [2008/07]
Applicant(s)For all designated states
Ind-Swift Limited
781 Industrial Area, Phase II
Chandigarh - 160 002 / IN
[N/P]
Former [2003/16]For all designated states
Ind-Swift Limited
781 Industrial Area, Phase II
Chandigarh - 160 002 / IN
Inventor(s)01 / Wadhwa, Hardeep
408, Shakti Apartments, Sector - 14
Panchkula, Haryana / IN
 [2003/16]
Representative(s)Bates, Philip Ian
Reddie & Grose LLP The White Chapel Building
10 Whitechapel High Street
London E1 8QS / GB
[N/P]
Former [2003/16]Bates, Philip Ian
Reddie & Grose 16 Theobalds Road
London WC1X 8PL / GB
Application number, filing date02256823.201.10.2002
[2003/16]
Priority number, dateIN1018DEL200101.10.2001         Original published format: IN DE20011018
IN1019DEL200101.10.2001         Original published format: IN DE20011019
[2003/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1302205
Date:16.04.2003
Language:EN
[2003/16]
Type: B1 Patent specification 
No.:EP1302205
Date:30.03.2005
Language:EN
[2005/13]
Search report(s)(Supplementary) European search report - dispatched on:EP04.03.2003
ClassificationIPC:A61K31/7048, A61K9/22
[2004/39]
CPC:
A61K31/7048 (EP,US); A61K9/1652 (EP,US); A61K9/1694 (EP,US);
A61K9/2018 (EP,US); A61K9/2077 (EP,US); A61K9/2866 (EP,US);
A61P31/00 (EP); A61P31/04 (EP) (-)
Former IPC [2003/16]A61K31/7048
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2003/16]
TitleGerman:Makrolidcitrat-haltige Formulierungen mit kontrollierter Freisetzung[2003/16]
English:Controlled release formulations of macrolide citrate salts[2003/16]
French:Composition pharmaceutique à libération contrôlée comprenant citrate de macrolide[2003/16]
Examination procedure13.10.2003Examination requested  [2003/50]
18.11.2003Despatch of a communication from the examining division (Time limit: M04)
15.03.2004Reply to a communication from the examining division
16.08.2004Communication of intention to grant the patent
13.12.2004Fee for grant paid
13.12.2004Fee for publishing/printing paid
Opposition(s)02.01.2006No opposition filed within time limit [2006/12]
Fees paidRenewal fee
12.01.2005Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.10.200403   M06   Fee paid on   12.01.2005
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBE30.03.2005
CH30.03.2005
EE30.03.2005
FI30.03.2005
IT30.03.2005
LI30.03.2005
NL30.03.2005
SK30.03.2005
SE30.06.2005
ES11.07.2005
CY01.10.2005
LU31.10.2005
MC31.10.2005
[2008/07]
Former [2007/38]BE30.03.2005
CH30.03.2005
EE30.03.2005
FI30.03.2005
IT30.03.2005
LI30.03.2005
NL30.03.2005
SK30.03.2005
ES11.07.2005
CY01.10.2005
LU31.10.2005
MC31.10.2005
Former [2007/20]BE30.03.2005
CH30.03.2005
EE30.03.2005
FI30.03.2005
LI30.03.2005
NL30.03.2005
SK30.03.2005
ES11.07.2005
CY01.10.2005
LU31.10.2005
MC31.10.2005
Former [2007/11]BE30.03.2005
CH30.03.2005
EE30.03.2005
FI30.03.2005
LI30.03.2005
NL30.03.2005
SK30.03.2005
ES11.07.2005
LU31.10.2005
MC31.10.2005
Former [2006/30]BE30.03.2005
CH30.03.2005
FI30.03.2005
LI30.03.2005
NL30.03.2005
SK30.03.2005
ES11.07.2005
MC31.10.2005
Former [2006/14]BE30.03.2005
CH30.03.2005
FI30.03.2005
LI30.03.2005
NL30.03.2005
SK30.03.2005
ES11.07.2005
Former [2006/01]BE30.03.2005
FI30.03.2005
SK30.03.2005
Former [2005/51]BE30.03.2005
FI30.03.2005
Former [2005/46]FI30.03.2005
Documents cited:Search[XDY]US5705190  (BROAD NEVILLE W [GB], et al) [XD] 1-4,6,9-11 * column 3, line 3 - line 25 * * column 4, line 35 - line 52 * * column 5, line 32 - line 48 * * table 1 * [Y] 1-26;
 [Y]WO0006531  (NICOX SA [FR], et al) [Y] 1-26* example 19 *;
 [Y]  - DUTTA S.K. ET AL., "Preparation of water-soluble salts of erythromycin and study of some of their properties", INDIAN DRUGS, (1980), vol. 17, no. 11, pages 354 - 356, XP001083744 [Y] 1-26 * page 354, column 2, paragraph 2 * * table 2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.